NCT03333135

Brief Summary

This research is being done to better understand the pulmonary consequences of completing an ultra marathon at altitude and a sea level city.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Dec 2016

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2016

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 6, 2017

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2021

Completed
Last Updated

April 11, 2022

Status Verified

April 1, 2022

Enrollment Period

4.5 years

First QC Date

October 27, 2017

Last Update Submit

April 1, 2022

Conditions

Keywords

UltramarathonsElectromagnetic field therapyEnduranceExerciseEnvironmental conditions

Outcome Measures

Primary Outcomes (6)

  • Change in right ventricle end diastolic area (EDA)

    Cardiac ultrasound (Philips CX50) will be performed to determine left and right ventricular morphology and function. Ultrasound will be performed in accordance with the recommendations of the American Society of Echocardiography guidelines (ASE). Imaging of the ventricles and the diameter during relaxation (diastole) will be captured and evaluated. Normal value for right ventricle EDA indexed to body surface area ranges between 5-12.6 cm\^2/m\^2 for males and 4.5-11.5 cm\^2/m\^2 for females .

    baseline, within 2 hours of race completion, 24-48 hours post race

  • Change in tricuspid annular plane systolic excursion (TAPSE)

    Another ultrasound metric that will be evaluated is tricuspid annular plane systolic excursion (TAPSE) which is used a parameter of global RV function which describes apex-to-base shortening. Normal value for TAPSE is above 16 mm.

    baseline, within 2 hours of race completion, 24-48 hours post race

  • Change in ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/e')

    Another ultrasound metric that will be evaluated is early mitral inflow velocity and mitral annular early diastolic velocity (E/e') which is used to evaluate the diastolic or relaxation function of the left ventricle. Normal value for E/e' is \<6.

    baseline, within 2 hours of race completion, 24-48 hours post race

  • Change in the ratio of peak velocity flow in early diastole (the E wave) to peak velocity flow in late diastole caused by atrial contraction (the A wave)

    Another ultrasound metric that will be evaluated is he ratio of peak velocity flow in early diastole (the E wave) to peak velocity flow in late diastole caused by atrial contraction (the A wave) (E/A) which is used to evaluate the diastolic filling of the left ventricle. Normal value for E/A is between 0.8 and 2.

    baseline, within 2 hours of race completion, 24-48 hours post race

  • Change in lung fluid assessed through ultrasound incidence of comet tails

    Ultrasound will be used to image 28 "windows" covering the 2nd through the 5th intercostal/rib space on the right and left sides of the chest. The number of comet tails observed over these 28 locations will be documented and the change in this number over the course of the study will be evaluated.

    baseline, within 2 hours of race completion, 24-48 hours post race

  • Change in lung fluid assessed through diffusion capacity of the lungs for carbon monoxide and nitric oxide

    Subjects will take a maximal breath of a test gas mixture, hold that inhalation for 4 seconds and then exhale and the exhaled gas will be analyze to determine the change in gas concentrations between what was inhaled and exhaled. Comparison will be made between the change over time in this ability of gas to move from the lungs to the blood stream.

    baseline, within 2 hours of race completion, 24-48 hours post race

Secondary Outcomes (6)

  • Change in exhaled nitric oxide

    baseline, within 2 hours of race completion, 24-48 hours post race

  • Change in hemoglobin

    baseline, within 2 hours of race completion, 24-48 hours post race

  • Change in hematocrit

    baseline, within 2 hours of race completion, 24-48 hours post race

  • Change in cardiac troponin I

    baseline, within 2 hours of race completion, 24-48 hours post race

  • Change in B-type natriuretic peptide

    baseline, within 2 hours of race completion, 24-48 hours post race

  • +1 more secondary outcomes

Study Arms (4)

HK100 Pulsed Electromagnetic Field

EXPERIMENTAL

20 athletes (ideally a mix of elite and amateur level athletes and veteran (40-65y) and young (20-39y). Athletes will be recruited at the 2018 and 2019 Hong Kong 100 races. In addition, these athletes will use the pulsed electromagnetic field (PEMF) for the two weeks prior to the race.

Procedure: Pulsed Electromagnetic Field therapy (PEMF)

HK100 Pulsed Electromagnetic Field Sham

SHAM COMPARATOR

20 athletes (ideally a mix of elite and amateur level athletes and veteran (40-65y) and young (20-39y). Athletes will be recruited at the 2018 and 2019 Hong Kong 100 races. In addition, these athletes will use a PEMF device that doesn't produce electromagnetic fields (sham) for the two weeks prior to the race.

Procedure: Pulsed Electromagnetic Field Sham therapy

UTMB Pulsed Electromagnetic Field

EXPERIMENTAL

20 athletes (ideally a mix of elite and amateur level athletes and veteran (40-65y) and young (20-39y). Athletes will be recruited at the 2018 and 2019 Ultra Trail du Mont Blanc (UTMB) races. In addition, these athletes will use the pulsed electromagnetic field (PEMF) for the two weeks prior to the race.

Procedure: Pulsed Electromagnetic Field therapy (PEMF)

UTMB Pulsed Electromagnetic Field Sham

SHAM COMPARATOR

20 athletes (ideally a mix of elite and amateur level athletes and veteran (40-65y) and young (20-39y). Athletes will be recruited at the 2018 and 2019 Ultra Trail du Mont Blanc (UTMB) races. In addition, these athletes will use a PEMF device that doesn't produce electromagnetic fields (sham) for the two weeks prior to the race.

Procedure: Pulsed Electromagnetic Field Sham therapy

Interventions

PEMF Therapy based on Biological Electromagnetic (BEM) microbial wave technology provides micro-magnetic emissions to the center of the palm (Laogong acupoint). While participating in the study, the subjects will undertake 2 sessions of therapy every day (1 session in the morning and evening). Each session will last for 16-min (8-min for left and 8-min for right hand).

Also known as: Bioboosti
HK100 Pulsed Electromagnetic FieldUTMB Pulsed Electromagnetic Field

PEMF therapy will be administered however it will not produce micro-magnetic emissions. The therapy will be used on the center of the palm (Laogong acupoint) of each hand. While participating in the study, the subjects will undertake 2 sessions of therapy every day (1 session in the morning and evening). Each session will last for 16-min (8-min for left and 8-min for right hand).

Also known as: Bioboosti Sham
HK100 Pulsed Electromagnetic Field ShamUTMB Pulsed Electromagnetic Field Sham

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy endurance trained individuals participating in the Ultra Trail du Mont Blanc (UTMB) and/or Hong Kong 100 ultramarathons

You may not qualify if:

  • \> 65 years age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Bruce D Johnson

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Study team and participants will not know if they have received the PEMF therapy or the sham
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 27, 2017

First Posted

November 6, 2017

Study Start

December 12, 2016

Primary Completion

June 15, 2021

Study Completion

June 15, 2021

Last Updated

April 11, 2022

Record last verified: 2022-04

Locations